Ozempic Alternatives: FDA-Approved Options, OTC Facts and What to Avoid

Ozempic alternatives fall into three very different groups. The first is other FDA-approved prescription drugs, including GLP-1 medicines such as Wegovy, Zepbound, Saxenda and Foundayo and older non-GLP-1 options such as phentermine, Qsymia and Contrave. The second is a single over-the-counter weight-loss drug, orlistat, sold as alli. The third is dietary supplements marketed as “GLP-1 support”, which are not drugs at all. There is no over the counter Ozempic and no OTC GLP-1 medicine in the United States. It also helps to know that Ozempic itself is approved for type 2 diabetes, not weight management; the weight-management version of the same drug, semaglutide, is Wegovy.

Peptide Labs does not sell Ozempic or any prescription GLP-1 medicine. We do carry alli, an OTC drug, which we mention below. This article is general information, not medical advice. Which medicine, if any, suits you is a decision for a licensed prescriber.

Ozempic alternatives at a glance

This table lists the FDA-approved GLP-1 medicines most often considered as alternatives to Ozempic, with their approved use and how often each is taken, as of September 2026. Every one requires a prescription.

Brand	Active ingredient	FDA-approved use	How often	First approved
Wegovy injection	Semaglutide	Weight management (adults, ages 12+); heart risk reduction; a form of fatty liver disease	Weekly	June 2021
Wegovy pill	Semaglutide	Weight management and heart risk reduction in adults	Daily	December 2025
Zepbound	Tirzepatide	Weight management in adults; sleep apnea with obesity	Weekly	November 2023
Mounjaro	Tirzepatide	Type 2 diabetes	Weekly	May 2022
Saxenda and generic liraglutide	Liraglutide	Weight management (adults, ages 12+)	Daily	December 2014 (generic August 2025)
Foundayo	Orforglipron	Weight management in adults	Daily pill	April 2026
Rybelsus and Ozempic tablets	Semaglutide	Type 2 diabetes	Daily pill	September 2019 (Ozempic tablet name February 2026)
Trulicity	Dulaglutide	Type 2 diabetes	Weekly	September 2014

Is there an over the counter Ozempic?

No. Ozempic and every other GLP-1 medicine require a prescription from a licensed healthcare professional. A pharmacist-reviewed Healthline guide, updated in August 2026, puts it plainly: you cannot get Ozempic or other GLP-1 medications over the counter, and websites or companies offering OTC Ozempic are unlikely to be safe. The two newest GLP-1 pills, the Wegovy pill and Foundayo, are prescription-only too.

The one weight-loss drug the FDA has approved for sale without a prescription is orlistat, sold as alli since February 2007. Kaiser Permanente’s health library, current as of February 2026, still describes it as the only FDA-approved over-the-counter weight-loss product. Orlistat is not a GLP-1 drug. It works in the gut to reduce how much fat the body absorbs from food. Its Drug Facts label limits use to overweight adults 18 and older who follow a reduced-calorie, low-fat diet, and warns about bowel changes such as gas with oily spotting and loose stools. We carry alli capsules; our guide to alli and orlistat covers the label, side effects and study results.

What OTC GLP-1 products really are

Products sold as OTC GLP-1 are dietary supplements, usually fiber, probiotics, berberine or plant extracts with “GLP-1” on the label. Under U.S. law the FDA does not approve supplements before they are sold, and their labels may describe support for normal body functions but cannot claim to diagnose or reduce the risk of disease. A supplement cannot legally contain semaglutide, and a product that did would be an unapproved drug. Our explainer on what “GLP-1 support” supplements are goes through common ingredients and how to read those labels.

Berberine gets the most attention, under the nickname “Nature’s Ozempic”. A 2026 meta-analysis of 23 randomized trials in the International Journal of Obesity found an average weight difference of 0.88 kg, about 2 pounds, compared with control groups, and its authors asked for better reporting of product purity and better blinding. That is a small fraction of what trials of GLP-1 drugs report. Our Nature’s Ozempic article covers the evidence and the drug interactions.

Prescription GLP-1 alternatives to Ozempic

Wegovy: the same drug with a weight-management label

Wegovy contains semaglutide, the same active ingredient as Ozempic, and was approved in June 2021 for chronic weight management. It comes as a weekly injection and, since December 2025, a daily pill. The two brands are approved for different uses and are not interchangeable. See Wegovy vs Ozempic for the label differences.

Zepbound and Mounjaro: tirzepatide

Tirzepatide acts on two hormone receptors, GIP and GLP-1. It was approved as Mounjaro for type 2 diabetes in May 2022 and as Zepbound for weight management in November 2023, and Zepbound is also approved for moderate to severe obstructive sleep apnea in adults with obesity. Both are weekly injections. Our semaglutide vs tirzepatide comparison summarizes the head-to-head evidence.

Saxenda and generic liraglutide

Liraglutide is an older, once-daily GLP-1 drug. Saxenda was approved for weight management in December 2014, and in August 2025 the FDA approved Teva’s generic version, the first generic GLP-1 medicine for weight management. See liraglutide vs semaglutide for how the daily and weekly drugs compare.

Tablets instead of injections

People who prefer not to use injections have three kinds of tablets to discuss with a prescriber. The Wegovy pill is oral semaglutide for weight management. Foundayo, approved on April 1, 2026, is a small-molecule GLP-1 drug for weight management that can be taken with or without food. Rybelsus, whose newer tablets now carry the Ozempic name, is oral semaglutide for type 2 diabetes. Our guide to GLP-1 pills compares their label rules.

Trulicity

Dulaglutide, sold as Trulicity, is a weekly GLP-1 injection approved in September 2014 for adults with type 2 diabetes. It is not approved for weight management.

All of these GLP-1 labels carry a boxed warning about thyroid C-cell tumors seen in rodents and say the drugs must not be used by people with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2.

Prescription alternatives that are not GLP-1 drugs

• Phentermine: a controlled-substance appetite suppressant labeled for short-term use of a few weeks, alongside diet, exercise and behavior changes.
• Qsymia (phentermine and topiramate): approved in July 2012 for adults and, according to NIDDK, children 12 and older; it has a safety program because topiramate can cause birth defects.
• Contrave (naltrexone and bupropion): approved in September 2014 for adults; its label carries a boxed warning about suicidal thoughts and behaviors linked to bupropion.
• Prescription orlistat (Xenical): a higher-strength version of the drug in alli.
• Imcivree (setmelanotide): approved only for specific rare genetic causes of obesity.

Our overview of prescription and supplement appetite suppressants explains how these work and who should not use them.

Compounded versions are not approved alternatives

Compounded semaglutide spread while the brand drugs were in shortage. The FDA declared the semaglutide shortage resolved on February 21, 2025, and its temporary flexibility for compounders ended in April and May 2025. Pharmacies may no longer routinely make copies of an approved drug unless a prescriber documents a real, patient-specific difference. The FDA stresses that compounded drugs are not FDA-approved and are not reviewed for safety, effectiveness or quality before sale. As of May 31, 2026, it had received 990 adverse event reports linked to compounded semaglutide and more than 730 linked to compounded tirzepatide. Our guide to compounded semaglutide and tirzepatide explains the rules in detail.

Counterfeit and illegal online semaglutide

In April 2025 the FDA seized several hundred units of counterfeit Ozempic that had entered the U.S. supply chain outside Novo Nordisk’s authorized channels. The agency warns that counterfeit drugs can contain the wrong ingredient, too little, too much or none at all. It also says that semaglutide sodium and semaglutide acetate, salt forms sold by some websites, are different active ingredients from the one in the approved drugs, and that products labeled “for research purposes” or “not for human consumption” are illegal and of unknown quality. On August 24, 2026, the FDA sent warning letters to five online sellers of semaglutide, tirzepatide and retatrutide, rejecting their “research use” labels. The FDA advises getting GLP-1 medicines only with a valid prescription from a state-licensed pharmacy; its BeSafeRx campaign explains how to spot a safe online pharmacy.

How to compare alternatives to Ozempic with a prescriber

• The reason for the prescription: diabetes drugs and weight-management drugs have different approved uses, even when they contain the same molecule.
• Injection or pill, daily or weekly: the table above shows the label facts.
• Your medical history: thyroid cancer history, pancreatitis, gallbladder disease, pregnancy plans and other medicines all matter.
• Coverage and supply: insurance rules differ by drug and by use, so ask the prescriber and pharmacy.
• Where it comes from: a licensed pharmacy, not a website selling research chemicals.

Frequently Asked Questions

Peptide Labs does not sell prescription GLP-1 medicines. This article is general information, not medical advice. For alli, read the Drug Facts label and follow its directions. For any prescription drug, read the Medication Guide and ask a pharmacist or prescriber how this information applies to you.

Last reviewed September 2026.

Related guides: Wegovy vs Ozempic: Same Semaglutide, Different Labels, Nature’s Ozempic: What Berberine and GLP-1 Foods Can and Cannot Do, Compounded Semaglutide and Tirzepatide: What Is Allowed Now, GLP-1 Pills: Every FDA-Approved Oral GLP-1 Compared (2026), GLP-1 Side Effects: What Every GLP-1 Drug Label Warns About, Phentermine: What It Is, Side Effects and Safety Facts, Contrave: How Naltrexone Bupropion Works, Side Effects and Results, Qsymia (Phentermine-Topiramate): Label Facts, Trials and Safety, GLP-1 for Weight Loss: What the Trials Actually Showed, Metformin for Weight Loss: What the Evidence Shows, Weight Loss Injections: What Is FDA-Approved and What Is Not, GLP-1 Drugs List: Every FDA-Approved Option in 2026, Generic Ozempic: Patents, Approvals and the U.S. Timeline.